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Abstract
At present the ability to create rationally engineered mutant rotaviruses is limited because of the lack of a tractable helper
virus-free reverse genetics system. Using the cell culture adapted bovine RV RF strain (G6P6 [1]), we have attempted to
recover infectious RV by co-transfecting in vitro transcribed ssRNAs which are identical in sequence to the positive sense
strand of each of the 11 dsRNA genomic segments of the RF strain. The RNAs were produced either from cDNAs cloned by a
target sequence-independent procedure, or from purified double layered RV particles (DLPs). We have validated their
translational function by in vitro synthesis of 35S-labelled proteins in rabbit reticulocyte lysates; all 11 proteins encoded by
the RV genome were expressed. Transfection experiments with DLP- or cDNA-derived ssRNAs suggested that the RNAs do
not act independently as mRNAs for protein synthesis, once delivered into various mammalian cell lines, and exhibit
cytotoxicity. Transfected RNAs were not infectious since a viral cytopathic effect was not observed after infection of MA104
cells with lysates from transfected cells. By contrast, an engineered mRNA encoding eGFP was expressed when transfected
under identical conditions into the same cell lines. Co-expression of plasmids encoding NSP2 and NSP5 using a fowlpox T7
polymerase recombinant virus revealed viroplasm-like structure formation, but this did not enable the translation of
transfected RV ssRNAs. Attempts to recover RV from ssRNAs transcribed intracellularly from transfected cDNAs were also
unsuccessful and suggested that these RNAs were also not translated, in contrast to successful translation from a
transfected cDNA encoding an eGFP mRNA.
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Introduction
Rotaviruses (RVs) infect the young of a large variety of
mammalian and avian species [1] and are a major cause of acute
gastroenteritis in infants and young children worldwide. They
cause more than half a million deaths per annum, mainly in sub-
Saharan Africa and South East Asia [2]. Since 2006, two live
attenuated RV vaccines [3,4] have been licensed in many
countries and are being widely used, often in universal mass
vaccination programs. In 2009, the WHO recommended their
worldwide application [5]. Vaccination has led to a significant
decrease in hospitalisation of infants for RV-associated acute
gastroenteritis [6,7,8] yet their overall effectiveness is under
scrutiny [9,10,11,12].
Rotaviruses form a genus of the Reoviridae family and possess a
genome consisting of 11 segments of double-stranded (ds) RNA
encoding 6 structural and 6 non-structural proteins [1]. RVs are
genomically and antigenically diverse, being classified into 7–8
species and recently (mainly species A) into RNA segment based
genotypes [13,14]. Like all RNA viruses, RVs have a high
mutation rate [15,16]. The genomes evolve through the mecha-
nisms of sequential point mutation, genome reassortment, gene
rearrangement, true genetic recombination, and (for human RV
infections) zoonotic transmission [17]. There is extensive published
research into the replication cycle and molecular pathogenesis [1],
but precise correlation between genotype and phenotype requires
engineered mutations of individual segments on a stable genetic
background. The technology to generate these genetically defined
viruses consists of reverse transcription of RV RNAs into cDNAs,
mutagenesis at the cDNA level, re-transcription of ssRNA from
cDNAs and incorporation of the mutated genes into viable
infectious viral progeny (virus rescue), a process termed ‘reverse
genetics’ (RG). Ideally RG systems do not depend on helper
viruses since separation of an engineered virus from an excess of
helper virus may be difficult, often requiring powerful specific
selection mechanisms. For other viruses of the Reoviridae such as
orthoreoviruses [18,19] and orbiviruses [20,21] helper virus-
independent, plasmid only-based RG systems have been estab-
lished. For RVs only helper virus-dependent systems have as yet
been developed; recently with the ability to stably incorporate
heterogeneous RNA sequences [22,23,24,25,26].
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Here we describe attempts to develop a helper virus-free RG
system for RVs by technologies successfully used in related RNA
viruses [20,21,27,28,29]. Our attempts have so far been unsuc-
cessful in rescuing infectious virus. However, we believe that
presentation of our data which identifies the significant stumbling
block of efficient protein expression from both RV cDNA and
ssRNA, despite using a combination of techniques, will be valuable
for the understanding of RV molecular biology. Additionally, the
conclusions derived from our data will assist the continued efforts
to develop a helper virus-free RG system and to further dissect the
intracellular mechanism by which RV ssRNAs are translated.
Results
Full Length Amplification of cDNA (FLAC) from RV RF
Genomic Template and Cloning of RV cDNAs
Applying full length amplification of cDNA (FLAC) technology
[30], which has been used to synthesise cDNAs of several members
of the Reoviridae [20,31], we successfully amplified all 11 segments
(Figure S1). The TOPO-TA pCR2.1 cloning kit (Invitrogen) was
used to shotgun-clone these products of the FLAC reaction.
Numerous clones were sequenced (Table S1) and used to generate
a consensus sequence for each segment (Table S2), applying
cogent GenBank sequences as a guide (Table S3). All cDNA clone-
derived sequences for each segment were aligned (including the
GenBank data) using ClustalX2 (unpublished data). Full sequences
of each segment used for the respective alignments and consensus
sequences can be found in GenBank (for accession numbers see
Tables S1 & S2). Individual clones possessing the consensus
sequence were used as templates for PCR to synthesize
transcriptional cassettes (Figure S2).
In silico Analysis of Consensus RV Sequences
Compared to the GenBank RF strain the consensus sequences
for segment 1, 6 and 9 were identical whereas segments 2–5 and 7,
8, 10 & 11 had point mutations. Segments 1 and 6 were used for
protein translation studies. We examined in silico the impact these
mutations might have on RNA structure to ensure that no
significant conformational changes were present which could
impair efficient translation. An extensive in silico analysis which
incorporated all available full length RV species A sequences for
each of the 11 segments identified potential stable long range cis-
acting interactions (LRI) between the 59 and 39 ends of almost all
segments [32]. Using RNAfold we compared each segment where
mutations had arisen to the structure produced from the GenBank
sequence. Figure S3 shows that the mutations had minimal effects
on the terminal RNA structures. Segments 2 and 7 showed the
greatest alteration in RNA structure but this only occurred at the
extreme termini of the RNA whilst the majority of the terminal
structure remained intact. Further comparison of our sequences
with the ConStruct data from Li et al., was unnecessary for
segments 1, 6 and 9 as there were no mutations between our
consensus and the GenBank sequence. For segments 8 and 11 no
predicted alterations to the RNA structures were found. Segment 8
encoded two mutations (N#63 & 64) which were a reversal of
nucleotides GC to CG in a stable stem structure. We also noted
that our segment 11 consensus sequence, which encoded an
additional U residue (N#4) was consistent with the consensus
sequence published by Li et al. [32].
Transcription in vitro of RV ssRNA from Recombinant
pUC19 Clones
Transcription templates were digested with the appropriate
restriction enzyme (RE) to define the 39 end of the RV segment
and then purified prior to in vitro transcription with T7 Pol. The
resulting ssRNA transcripts were analysed by TBE-AGE as shown
in Figure 1. Nine of 11 templates produced a unique ssRNA band
of the appropriate size. Transcription products of segment 3 and
6 cDNA templates each migrated as double bands, one of the
expected full length ssRNA and a second smaller transcript. The
same dual product was seen for both segments when PCR
amplicons were used as transcription templates (unpublished data),
strongly suggesting that the shorter ssRNA had resulted from
premature termination of transcription [33]. To ensure the bands
were not gel-related artifacts, samples were separated by
denaturing urea PAGE, and the same profile was seen (unpub-
lished data). BLAST analyses did not detect intragenic sequences
similar to the T7 Pol promoter or terminator sequences of segment
3 and segment 6 (unpublished data).
ssRNA Synthesis from Purified DLPs of Several RV Strains
Purified RV DLPs can transcribe positive ssRNA in vitro from
the dsRNA genomic segments packaged in the particles
[34,35,36]. RNAs extruding from DLPs are positive sense and
should possess authentic in vivo structures to facilitate experiments
aimed at recovering infectious RV. DLPs of five different RV
strains were used; the yields of ssRNA were between 3 and 10 mg
of purified ssRNA per mg of purified DLPs. Figure 2 shows the
successful synthesis of ssRNAs from the DLPs of all strains used
alongside a ssRNA marker. The AGE migration patterns in
Figure 2, lanes 2–6 reveal the genome structure of each strain.
Thus, it was possible to identify ssRNAs derived from DLPs
containing rearranged genomes (lanes 4 and 5).
In vitro Synthesis of an eGFP-encoding mRNA
We used a commercial vector (pEGFP-N1; Clontech) to create
an in vitro transcribed mRNA so that the autofluorescence of
expressed enhanced GFP (eGFP) could be used as a marker for the
efficiency of RNA transfection into mammalian cells. The
requirement for a reporter ssRNA relying on conventional
mammalian translation machinery rather than utilising RV UTRs
was essential as it has been shown that a transfected luciferase
reporter gene flanked with the UTR of gene 6 was only expressed
efficiently in cells already infected with RV [37]. Furthermore a
recent publication has demonstrated that ssRNA transfection of a
chimeric mRNA also utilising RV segment 6 UTRs to control
translation was less efficient than a globin control [38]. Using
similar technology to that described above, the eGFP ORF was
amplified using PCR with primers which introduced a T7 Pol
promoter fused to the 59 end of the transcriptional start point and
a BsmBI site to define the 39 end. BsmBI-digested T7 eGFP
amplicons were used as a template for in vitro transcription as
described, and transcripts were additionally polyadenylated using
E. coli poly (A) polymerase (Ambion) to resemble mammalian
mRNAs. Samples of uncapped, post-transcriptionally capped
(‘post-capped’) and co-transcriptionally capped (‘co-capped’) eGFP
ssRNA were analysed by AGE (Figure 3, lanes 1, 2 and 5,
respectively). Samples of uncapped, post-capped and co-capped
polyadenylated eGFP ssRNAs were also analysed (Figure 3, lanes
3, 4 and 6, respectively). Figure 3 shows that uncapped, post-
capped and co-capped ssRNAs all migrate at the same rate and
that the three respective polyadenylated RNA species also co-
migrated, although at an expected slower rate.
Towards a Rotavirus Reverse Genetics System
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In vitro Translation of Proteins from in vitro Transcribed
RV RNA
There are many published examples of in vitro translation of RV
RNAs, derived from either DLPs or transcribed in vitro from
cDNA [39,40,41,42]. To ascertain whether the in vitro transcribed
RV ssRNAs function as mRNAs, we tested them in vitro using
rabbit reticulocyte lysates (RRL). The efficiency of translation was
higher with ssRNA transcripts which had been post-transcription-
ally capped (unpublished data). We performed individual in vitro
translations with all 11 post-capped RV RNAs transcribed in vitro
from cDNA. Figure 4 shows an autoradiograph of the translation
products. All 11 RV RNAs generated proteins of the expected
size, with the largest proteins encoded by segments 1–4 being
synthesised at lower efficiencies. Higher expression of the smaller
RV proteins, even at equimolar amounts of ssRNA, has been
observed before [43]. Figure 4, panel A shows successful synthesis
of the RV structural proteins. Segment 3 RNA, VP3, has a
significantly lower level of protein expression when compared to
segment 2 RNA, VP2, which encodes a protein of comparable
size. The discrepancy between the protein yields could be due in
part to the fact that in vitro transcription from the RF segment 3
template produced two products (Figure 1, lane 3) only one of
which corresponds to the full length RNA. Alternatively the
presence of at least two predicted stable stem structures in RNA3
may have contributed [32]. The level of VP6 expression is very
high (Fig. 4, panel A, lane 5). This is not an artifact of a high
methionine residue content relative to the protein’s molecular size
when compared to the other RV proteins. It has been
hypothesised that VP6 may have its own segment-specific
enhancer sequence promoting its own translation [44], and a
stable stem loop structure has been mapped using in silico analysis
to the same region [32]. Figure 4, panel B shows the synthesis of
the RV non-structural proteins. In panel B, lane 4, NSP4 migrates
faster than would be expected based on its molecular weight of
20 kDa, highlighted by comparison with the migration of NSP5
Figure 1. Agarose gel electrophoresis of the in vitro transcribed ssRNAs of the 11 RF RV segments. In vitro transcribed viral positive
sense RNA, transcribed in the presence of a cap analogue from linear templates with a RE digested 39 end. 200 ng of each ssRNA transcript was
loaded onto the gel; 1.5% TBE AGE 80 V for 45 min. Lane R: RiboRulerTM High Range RNA markers (in bases); lanes 1–11: positive sense co-capped RV
RF ssRNAs corresponding to segments 1 to 11, respectively.
doi:10.1371/journal.pone.0074328.g001
Figure 2. ssRNA derived from several strains of RV DLPs. ssRNA
were synthesized in vitro from purified RV DLPs. DLPs were incubated at
37uC for 2 hours with the necessary components for positive sense
ssRNA synthesis. 1.5% TBE AGE 45 V for 120 min. Lane R: RiboRulerTM
High Range (in bases); 1.5 mg ssRNA derived from DLPs of RV strains
SA11, OSU, RF, 125 and 128, respectively. DLP-derived ssRNAs 2 and 3
comigrate in all samples., ssRNAS 7–9 comigrate in SA11, OSU and RF,
but only ssRNAS 7 and 9 comigrate in 125 and 128. Arrows indicate the
altered migration of ssRNAs synthesised from the templates of
rearranged genomic segments (RS). RS8, RS11 rearranged segment 8
or 11, respectively, of RV strains 125 and 128.
doi:10.1371/journal.pone.0074328.g002
Figure 3. eGFP ssRNA species produced in vitro. ssRNAs were
synthesised from PCR-derived amplicons with a T7 Pol promoter
introduced at the 59 end to facilitate in vitro transcription. PCR
amplicons were digested with BsmBI to define the 39 end of the
transcription cassette. Templates, either 500 ng or 1 mg, were incubated
with T7 Pol in the absence or presence of a cap analogue using
MEGAscriptH or Mmessage MmachineH. Uncapped ssRNAs were
purified and post-transcriptionally capped using ScriptCapTM m7G
Capping System. ssRNA was polyadenylated using E. coli polyadenyl-
ation polymerase (ePAP) Ambion. Lane R: RiboRulerTM High Range;
lanes 1–6: approximately 250 ng each of eGFP ssRNA; uncapped, post-
capped, uncapped polyadenylated, post-capped polyadenylated, co-
capped, co-capped polyadenylated, respectively. 1.5% TBE AGE 60 V for
–90 min. The polyadenylated RNA bands are less sharp as the molecules
differ in the numbers of A residues added at the 39end.
doi:10.1371/journal.pone.0074328.g003
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(21 kDa) (lane 5). This phenomenon has been observed before
[42,43]. The molecular sizes of NSP4 and NSP5 are very similar,
and both proteins are calculated to possess a small negative charge
at pH 8.8 (Scripps web protein calculator v3.3). It is possible that
the protein product seen is actually a truncated version of NSP4
after cleavage by proteases in the RRL. N- and C-terminal protein
sequencing would identify a truncation if this was the case. The
translation reactions of all RV RNAs show several bands
migrating faster than the molecular weight of the authentic
protein encoded in the ssRNA template. This is likely due to
premature termination of protein synthesis, and Western blot
could be used to reconfirm the identity of the largest protein in
each reaction., The multiple band profiles are not RV specific as
they are observed in both the RV samples and the XEF positive
control (Figure 4, panel B). As the largest product from each
reaction migrates at the expected size of the RV encoded in the
ssRNA, we concluded that all RF RV ssRNAs can function as
templates for protein synthesis using the mammalian translational
machinery.
We also tested the translation capacity of the DLP-derived
ssRNAs of the strains we had used. We incubated DLP-derived
transcripts and mixtures of all 11 segments from co-capped or
post-capped ssRNAs of the RF strain, in RRL. Figure 5, lanes 3
and 4 demonstrate that cohorts of the post-capped ssRNAs are
translated with greater efficiency than cohorts of co-capped RNAs.
Comparison between lanes 3, 4 and 5 reveals highly similar
protein translation profiles for the cDNA-derived and DLP-
derived ssRNAs of the same strain (RF). While the presence of
every RV protein would require complex Western blot analysis,
the striking resemblance between the protein profiles of synthet-
ically generated and DLP-derived ssRNA cohorts provides
compelling evidence that the ssRNAs are functional templates
for protein synthesis.
The poor translation of segment 3 RNA of the RV RF strain is
supported by similar findings with the bovine RV UK Compton
strain [43] whose sequence is very similar to that of the RF strain.
We investigated the transcription products of segment 3 cDNA of
the SA11 simian RV strain which encodes a similar VP3 (cloned
into a T7 Pol transcription cassette from genomic dsRNA by RT-
PCR) and obtained only a single RNA band of the correct size
(Figure S4, panel A, VP3). To ascertain whether the SA11 ssRNA
Figure 4. In vitro translation of RV proteins using S1 - 11 in vitro transcribed ssRNAs. In vitro translation using all in vitro transcribed RV
ssRNAs as templates for protein synthesis. 500 ng of ssRNA was incubated in RRL with 35S L-methionine for 3 hours and analysed using SDS-PAGE.
The dried gel was exposed to X-ray film for 36 hours. Panel A, 15% SDS - PAGE, contains the in vitro translated RV structural proteins; VP1, VP2, VP3,
VP4, VP6 and VP7, respectively. Panel B, 12% SDS-PAGE, contains the in vitro translated RV non-structural proteins; NSP1, NSP2, NSP3, NSP4 and NSP5,
respectively. Lane 6: Xenopus elongationfactor 1a (XEF) (positive control); lane 7: no ssRNA, (negative control). The sizes of protein markers run
alongside during SDS-PAGE are indicated in kDa to the left of the autoradiographs.
doi:10.1371/journal.pone.0074328.g004
Figure 5. In vitro translation of RV proteins from cohorts of
cDNA-derived and DLP-derived ssRNAs. In vitro translation of RV
DLP derived ssRNAs. 1 mg of capped DLP ssRNA was incubated in a RRL
as described, electrophoresed on a 15% SDS-PAGE alongside PageR-
ulerTM protein markers (in kDa) and exposed to X-ray film for 4 days.
Lane 1: no ssRNA; lane 2: XEF ssRNA; lanes 3 & 4: S1–11 post-capped or
co-capped ssRNA respectively; lane 5: RV ssRNAs from RV RF strain
DLPs. The sizes of protein markers run alongside SDS-PAGE are
indicated in kDa to the right hand side and were used to predict the
location of RV proteins.
doi:10.1371/journal.pone.0074328.g005
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is a more efficient template for protein synthesis, we compared
segment 3 in vitro transcripts of RF and SA11 RV strains as
templates of protein synthesis in vitro. The RNAs of both strains
produced very similar protein expression profiles, but the amount
of protein translated from the RNA of SA11 is at least double that
of RF (Figure S4, panel B, lanes 2 & 3).
Optimisation of ssRNA Transfection using an eGFP
Reporter mRNA
To optimise transfection with large ssRNAs, we initiated pilot
experiments using a specifically constructed reporter eGFP
mRNA. We transfected COS-7 cells in parallel with in vitro
synthesized ssRNA and a DNA plasmid (pEGFP-N1) both of
which encode an identical eGFP ORF (718 bp) under the control
of the same Kozak enhancer sequence. The ssRNA was either co-
transcriptionally or post-transcriptionally capped and then poly-
adenylated. Figure 6 demonstrates that the post-capped ssRNA
was 23% more efficient as a template for protein synthesis than the
co-capped ssRNA (quantitation not shown). The expression of
eGFP was detectable with as low as 5–10 ng of transfected ssRNA,
however, the transfection efficiency in MA104 cells was lower than
that seen in COS-7 cells (unpublished data). A comparison of
different transfection reagents (Lipofectamine 2000 (Invitrogen),
Jet prime (PolyPlus), X-tremeGENE (Roche), turbofect (Fermen-
tas) and TransIT-mRNA (Mirus) demonstrated that for ssRNA
transfection the Mirus reagent was optimal, whereas for cDNA
transfection it was Lipofectamine 2000 (unpublished data). We
used a mammalian (rather than a RV) based expression cassette
for the eGFP control ssRNA as previous data have shown that
reporter genes (encoded by DNA or RNA) flanked with RV UTRs
from gene 6 are not efficiently translated [37,38]. Thus an eGFP
ORF flanked with viral UTRs might be equally poorly translated
and provide an inadequate positive control. Additionally the
presence of the RV UTRs would not answer the question as to
whether the UTRs were solely responsible for the efficient
translation. The use of the eGFP reporter mRNA was crucial to
validate the transfection experiments.
Transfection of in vitro Transcribed and DLP-derived RV
ssRNAs
We transfected COS-7, MA104 and 293T cells with cohorts of
the in vitro transcribed ssRNAs in Opti-MEM I, using the Mirus
transfection reagent. Cells were transfected with cohorts of
ssRNAs, ranging in mass from 10 ng –2 mg (each segment
representing 1/11th of the total mass) or equimolar concentrations
of each ssRNA. Protein expression or nascent viral formation was
sought. All three cells lines showed significant cytopathic effects
after 24 hours, progressing to almost total cell destruction (60 -
80%) at day 3 post transfection. Media or frozen and thawed
lysates from transfected cells were inoculated onto fresh MA104
monolayers to test for infectious virus but none was detected at
7 days. It was recently shown that BTV rescue was enhanced by
double transfection of ssRNAs [45]; we thus transfected two
cohorts (S1–S11) of RV ssRNA segments 16 hours apart. We
hypothesised that, S1, S2, S3, S6, S8 and S11, encoding VP1,
VP2, VP3, VP6, NSP2 and NSP5, respectively, might form the
minimum essential group of proteins for initial viroplasm and DLP
formation. The second transfection step contained all 11 ssRNAs.
(We also added the SA11 RNA 3 to the RNAs of the RF RV strain
in some experiments). Viable viral progeny was not detected (in
MA104 cells) from the cell extracts of these experiments.
Transfections (single or double) of cells with DLP-derived ssRNAs
of five RV strains (RF, SA11, OSU, 125 and 128) were similarly
unsuccessful (unpublished data). To ascertain whether RV ssRNA
transcripts had actually entered cells, the cohort of S1–S11
ssRNAs was mixed with eGFP ssRNA and transfected as an
ensemble of 12 ssRNA transcripts. eGFP expression was observed
in many cells, however the supernatant from this experiment
yielded no progeny virus (unpublished data). We hypothesised that
the full length RV ssRNAs were not autonomously infectious, but
it was unclear whether this was due to a lack of protein translation,
potent innate immune responses, a high degree of cytotoxicity
exerted by the transfected RNAs or a combination of more than
one of these factors. To investigate this we transfected cells and
sought RV protein expression using specific antibodies. Figure 7
shows the results for individual and ensemble ssRNA transfection
experiments in COS-7 cells. Cells were transfected with varying
amounts of a variety of ssRNAs, either cDNA- or DLP-derived,
and incubated for 24 hours prior to fixing and staining with RV
specific antibodies (for details see legend of Figure 7). There was
no detectable NSP2 or NSP5 expression in any of the transfection
experiments (and consequently no VLS formation). Similar
observations were made in MA104 and 293T cells, VP1
expression was similarly undetectable (unpublished data). We
then hypothesised that expressing RV proteins in cells prior to RV
RNA transfection might be necessary to permit RV protein
synthesis from ssRNAs under these conditions. Co-expression in
trans of NSP2 and NSP5 six hours before, or simultaneously with,
RV ssRNA transfection failed to yield infectious progeny virus
(unpublished data). An MA104 cell line constitutively expressing
NSP5-eGFP [46], was transfected with S8 ssRNA encoding NSP2,
but we saw no VLS formation by immunofluorescence (unpub-
lished data).
Transfection with Polyadenylated RV ssRNAs
It was plausible that rapid delivery to cells of highly structured
ssRNAs in large amounts might trigger the innate immune
response, possibly leading to cell cycle arrest through mechanisms
such as interferon induction. As RV ssRNAs are not naturally
polyadenylated whereas the reporter eGFP RNA was, we
hypothesized that this might selectively flag the viral RNAs for
degradation prior to translation [47]. We therefore polyadenylated
the RV ssRNAs post-transcriptionally. We were aware that the
disruption of the native 39 end, which is highly conserved in RVs,
could have significant negative implications for replication and
packaging of ssRNAs [37,48,49,50,51]. However, had protein
expression occurred this might have facilitated authentic ssRNA
translation from a subsequent transfection. We performed this
experiment with individual in vitro transcribed RV ssRNAs and a
variety of ssRNA ensemble mixtures. Figure S5 shows the
successful polyadenylation of 4 ssRNAs (S1, S8, S9 & S11).
However, this did not lead to detectable gene expression after
transfection (Figure S6). Analogous experiments with polyadenyl-
ated DLP-derived ssRNAs did not lead to detectable protein
expression either and transfection of the polyadenylated RV
ssRNA into Vero cells, which are deficient in interferon
production [52,53] also did not lead to detectable RV protein
expression (unpublished data).
RV Protein Detection by Western Blot
We sought evidence of RV protein expression by Western
blotting COS-7 cell lysates transfected with RV ssRNAs. Figure 8,
panel A clearly shows that neither VP1 nor NSP5 proteins were
detected from cells transfected with DLP-derived or cDNA-
derived in vitro transcribed RV ssRNA, with or without polyad-
enylation. To validate the Western blot procedure, the membrane
section was reprobed using an eGFP-specific antibody (Figure 8,
Towards a Rotavirus Reverse Genetics System
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panel B, lane 2); eGFP protein was easily detected. To address the
question of differing viral protein translation efficiencies, we also
examined the expression of two additional structural proteins, VP2
and VP6 (Figures S7 and S8). Our selection of these two proteins
was due to the high copy number required for RV particle
formation, VP6 is known to be the most abundantly expressed
structural protein [54] and has a segment specific enhancer in
addition to the RV specific 39 translational recognition sequence
[55,56]. We concluded that neither unmodified nor polyadenyl-
ated RV ssRNAs, obtained from either in vitro transcribed cDNAs
or from DLPs, can act as efficient templates for protein synthesis
when transfected into cells and therefore, by definition, were not
autonomously infectious.
Recombinant Fowlpox virus Expressing T7 RNA
Polymerase as a Tool to Drive Intracellular Transcription
of PCR Synthesised RV Segmental Amplicons
A recently developed RG system for a positive sense ssRNA
virus, the enteropathogenic norovirus, utilised recombinant
fowlpox virus (FPV) which expresses T7 RNA polymerase (FPV-
T7) [29,57]. FPV cannot replicate in mammalian cells [58] and is
of very low cytopathicity [59]. Published data on the helper virus-
dependent RV reverse genetics system has shown RV and vaccinia
recombinant virus superinfections in combination with transfected
DNA templates can produce recombinant RVs [23,25]. To test
this system, we used infection with FPV-T7 to transcribe RV
ssRNA from transfected linear cDNAs intracellularly (the
amplicons are shown in Figure S2).
Once we had validated the experimental protocol with the T7-
eGFP amplicon, we examined whether intracellular transcription
of RV positive sense RNAs from transfected cDNA could enhance
protein expression, or produce infectious RV particles. We
transfected cDNA templates of segments 11 (T7RF11) and
segment 8 (T7RFS8) into COS-7 cells. Figure 9 shows the absence
of detectable protein expression when linear DNA templates
encoding either NSP2 (panel D) or NSP5 (panel F) were
transfected. Several cells (,20 in total) in panel D (transfected
with S8 [NSP2] cDNA) showed green fluorescence. However, this
was also seen in the FPV-T7-only infected control (Panel A). We
attributed this effect to non-specific binding of NSP2 antibody to
apoptotic cells. These artifacts were not observed with the NSP5
specific antibody (panel F). When the cohort of 11 RV cDNAs was
transfected into FPV-T7 infected cells, no infectious RV progeny
was rescued (unpublished data). It was reasonable to assume that
Figure 6. Comparison of fluorescence between transfected eGFP RNA species. COS-7 cells at 80% confluence, incubated in Opti-MEM I
media were transfected with eGFP ssRNA using Lipofectamine 2000. Cells were stained with Hoechst 33342 and live imaged in an epifluorescence
microscope at 24 hours post transfection. Panel A: mock transfected cells. Panels B & C: cells were transfected with 750 ng of eGFP ssRNA either post-
capped or co-capped, respectively. Cells were exposed to UV (nuclei staining), blue light (eGFP excitation) or merged, respectively.
doi:10.1371/journal.pone.0074328.g006
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Figure 7. Transfection of COS-7 cells with in vitro transcribed ssRNAs encoding RV ssRNAs and DLP derived ssRNAs. COS-7 cells at
80% confluence were transfected with ssRNAs encoding RV proteins using Mirus transfection reagent. Cells were fixed at 24 hours post transfection
and stained with NSP2 and NSP5-specific antibodies (Table S4). Images were analysed by confocal microscopy. Panel A: transfection with cohorts of
in vitro transcribed ssRNAs, 1 mg of S1– S11, post-capped (PC) or co-capped (CC) respectively, stained for both NSP2 and NSP5. Panel B: 1 mg of DLP
Towards a Rotavirus Reverse Genetics System
PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e74328
the cDNA amplicons were transfected successfully into cells and
probably acted as templates for intracellular transcription, as
eGFP was expressed from a transfected linear amplicon however
the RV ssRNA transcripts were apparently not competent for
efficient translation.
Utilising VLS to Rescue RV after ssRNA Transfection
We reasoned that the creation of pre-existing VLS from co-
expression of plasmids encoding NSP2 and NSP5, under the
control of T7 Pol promoter, might create a cellular environment
more favourable to RV protein translation from ssRNAs. We
tested this hypothesis in MA104 cells where VLS were formed
(Figure 10). Subsequent transfection with the cohort of ssRNAs or
just segment 1 alone did not yield protein expression or rescue
infectious virus. VLS were also formed in COS-7 and Caco-2 cells
but upon RV ssRNA transfection we did not observe correspond-
ing RV protein expression or rescue of infectious virus (unpub-
lished data).
Discussion
Exploring RV replication at the molecular level has been
hampered by the lack of a technology which permits rescue of
genetically defined RVs in the absence of a helper virus. More
recently several helper virus-dependent RG systems for RVs have
been established, but they all require a strong selective pressure
against the helper virus, are cumbersome and are not universally
applicable to all RVs or all RV segments [22,23,24,25].
Furthermore the possible effects of strong selection methods
(antibodies or siRNAs) on the formation of recombinant RVs are
unknown. For several viruses of other genera of the Reoviridae
family ssRNAs of positive sense polarity produced by methods
analogous to those investigated in this paper (in vitro from cDNAs
or from viral cores/subviral particles) can, under the correct
conditions, initiate a replication cycle, permitting rescue of
infectious virus progeny [18,19,20,27,45]. The approach of using
RV ssRNA to develop a helper virus-free RG system was
supported by the finding that RV replication profoundly
suppresses certain host cell processes [38]. Transfection of RV
DLPs into susceptible cells can initiate an infection [60], yet a
protocol to engineer a helper virus-free RG system for RVs has not
as yet been published.
We modelled our approach on the successful protocol for
engineering a RG system in viruses of the Orbivirus genus
[20,21,27]. Since both BTV and RVs share many structural and
replication characteristics, we used the FLAC procedure [30] to
amplify and subsequently clone the RV genome, a technique
which has recently been applied to the amplification of cDNAs of
other multisegmented dsRNA viruses [31].
Shotgun cloning RV cDNAs necessitated complete sequencing
of several clones for each segment. The sequences obtained from
the clone library were nearly identical to those already available in
GenBank which have been used in a variety of studies
[61,62,63,64,65,66]. We assumed that the GenBank sequences
of the RV RF strain were an accurate representation of their
genetic composition and the majority of mutations detected
occurred in the UTRs of each RNA, thus not affecting the protein
structure. It is possible that the mutations could affect packaging
efficiency but it is generally accepted that the UTRs and part of
the adjacent ORFs of RV RNAs are likely to be important for
efficient packaging [45,67] and the importance of viral protein-
RNA and protein-protein functions was not related to the major
obstacle we discovered; inefficient translation from full length RV
RNAs either directly transfected into cells or synthesised from
cDNAs transfected into the cytoplasm. Using the clonal sequences,
consensus sequences were generated from which we constructed
11 RV T7 Pol transcription templates which permitted in vitro
synthesis of positive sense RNAs with native 59 and 39 ends for
each of the 11 RV genome segments. Synthesis of a full genomic
complement of RV RNAs using this method has not previously
been reported, and the system may have applications in other
aspects of RV replication such as RNA analysis. We also
synthesized DLP-derived ssRNAs from CsCl gradient purified
DLPs [35,36].
We noted double bands in the in vitro ssRNA transcription
products of RV segments 3 and 6. One band of each was
consistent with the full length product; the other one was smaller.
Another publication has found comparable results when in vitro
transcribing the influenza H5N1 virus HA RNAs [33], where
faster migrating bands were attributed to premature in vitro
transcription termination due to a type II RNA hairpin loop
terminator [33]. This is a plausible assumption for RV segments 3
and 6 as we know that RV ssRNA segments are highly structured
[32]. When we produced a positive sense ssRNA transcript of a
segment 3 cDNA of the simian SA11 rotavirus strain only one
product of the expected length was obtained.
We demonstrated successful translation of all 11 RV proteins
derived from both the in vitro transcribed and the DLP-derived
ssRNAs in the RRL. When cohorts of all 11 ssRNAs obtained
derived ssRNAs from RV strains RF, 125 and 128 respectively, stained for both NSP2 and NSP5. Panel C: individual or co-transfection of 500 ng of
ssRNAs S8, S11 or both stained for NSP2, NSP5 or both, respectively. Panel D: immunofluorescence of control MA104 cells infected with RF RV, stained
for NSP2 and NSP5, transfection control with 1 mg of eGFP ssRNAs (autofluorescence), mock transfection stained for NSP2 and NSP5. Cell nuclei were
stained with Hoechst 33342 in all panels. Scale bars: 20 mm.
doi:10.1371/journal.pone.0074328.g007
Figure 8. Absence of VP1 and NSP5 expression from trans-
fected ssRNAs by Western blotting. COS-7 cells were transfected
with 1 mg of RV ssRNA using the Mirus TransITTM mRNA transfection
reagent. Expression of RV proteins from cell lysates was sought by
Western blot. Panel A, the membrane was split into three sections, to
ascertain the presence of VP1, 170–70 kDa, loading control a tubulin, 70
- 40 kDa and NSP5, 40–15 kDa. Each section was incubated with the
respective primary and secondary horseradish peroxidase (HRP)
conjugated antibody (Table S5). Panel B, corresponding to the 40–
15 KDa portion of membrane A which was reprobed for eGFP (Table
S5). Proteins were visualised using the ECL Western blot detection
reagents, light sensitive film was exposed to membranes for varying
lengths of time depending on band intensity. Lane 1: mock; lanes 2–8
in vitro transcribed or DLP derived ssRNAs of: 2: eGFP, 3: S1– s11, 4: S1,
5: S11, 6: DLP RF, 7: S1 polyadenylated, 8: S11 polyadenylated; 9: COS-7
infected RV RF cell lysate.
doi:10.1371/journal.pone.0074328.g008
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from DLPs or cDNAs were used they translated into identical
protein patterns, suggesting that the cDNA-derived ssRNAs were
as functionally capable as DLP-derived RNAs for the synthesis of
RV proteins.
Cohorts of DLP-derived or in vitro transcribed ssRNA molecules
were co-transfected into a variety of cell lines capable of
supporting RV infection (COS-7, MA104, Vero, 293T cells), but
were not infectious as judged by the failure to rescue infectious
virus from transfected cell extracts by subsequent passages on
MA104 cells. The transfection procedure for RV ssRNAs, similar
to that of other orthoreoviruses [20,21], was validated using a
reporter mRNA encoding eGFP.
A large variety of strategies were assessed to attempt to generate
a functional RG system. The recently published approach for
AHSV RG indicated an improved yield of rescued virus using a
dual transfection system where two different cohorts of ssRNAs
were transfected 16 hours apart [21]. We tested this using two
different cohorts of RV ssRNAs (1. S1, S2, S3, S6, S8 & S11; 2.
S1–S11; transfected 16 h apart) but without success.
Cytotoxicity following ssRNA transfection was observed in all
cell lines used. The level of cytotoxicity did not correlate with the
total amount of RNA transfected as identical masses of transfected
eGFP ssRNA resulted in protein expression and comparable
experiments with RV ssRNAs did not yield protein expression.
Cytotoxicity was also observed when cohorts of 6 ssRNAs or
individual RNAs at varying masses were transfected, and in no
case was protein expression detected. Conditions for ssRNA
transfection were extensively and carefully explored and particular
attention was paid to replicate the published experimental
conditions for large cohorts of ssRNAs [20,27,45,68,69].
To examine protein expression efficiency, we tested protein
expression from transfected ssRNAs using immunofluorescence
and Western blotting techniques. We investigated VP1, VP2, VP6
NSP2 and NSP5 expression from their encoding RNAs in a
variety of transfection experiments, but we were unable to detect
RV protein expression at any time. Even transfected DLP-derived
ssRNAs were incapable of intra-cytoplasmic protein synthesis.
Transfected naked RV ssRNAs, unlike the co-transfected eGFP
ssRNA, were not competent templates for protein synthesis. It is
worth noting that both BTV and AHSV ssRNAs synthesised from
cores, which also lack a 39 polyadenylation sequence, can form
nascent viruses post transfection into BSR cells [21,27] but this
phenomenon is yet to be described for RV. From these data we
concluded that despite the ssRNAs being used for in vitro
translation in RRL, efficient translation inside mammalian cells
was blocked.
The lack of success with the procedures discussed above led us
to question whether the transfected ssRNAs were functional as
templates for protein synthesis once present in cells as the RNAs
produced were clearly recognised by mammalian translational
machinery in vitro. We dismissed the possibility that the ssRNAs
were rapidly being degraded because there is strong published
evidence showing that RV ssRNAs are stable post transfection into
RV infected or uninfected cells [70]. In addition our experiments
using the control eGFP encoding ssRNA demonstrated that RNA
stability and translation of mammalian transcripts were not an
issue. Attempts at camouflaging RV ssRNAs to appear more akin
to a cellular transcript were also unsuccessful in enhancing protein
expression. Furthermore, protein expression was not detected
when ssRNA transcripts synthesised from purified DLPs were
transfected into cells yet the same DLP preparations were capable
of initiating an infection after transfection. Our findings clearly
indicate when viral transcriptional machinery is used to synthesise
RV ssRNAs transcripts, the intracellular location of transcription
is crucial. Therefore we concluded that our RV ssRNAs must not
have been recognised efficiently after transfection.
It is possible that nascent RV proteins or particles were formed
during our experiments but at a level that was undetectable. We
attempted to address these issues by repeating transfections of
ssRNAs to enhance viral protein translation which has been shown
to enhance viral yields [21,45], analysed concentrated amounts of
cell lysates (20/30% of cell lysate per lane) transfected with
Figure 9. FPV-T7-driven intracellular transcription and translation from transfected linear DNA templates of NSP2 and NSP5. COS-7
cells infected with FPV-T7 Pol for 1 hour and transfected with 1 mg of linear PCR amplicon encoding either RV segments 8 or 11 or EGFP. pcDNA3-
NSP2 and pT7V-NSP5 were used as protein controls. Cells were incubated for 24 hours, prior to fixing and staining for RV proteins as previously
described. Cells transfected with EGFP were only stained with Hoechst 33342. Samples were imaged using a fluorescence microscope. All panels were
exposed to UV light, panels A, B, C, and D were exposed to blue and panels E and F were exposed to green wavelengths of light. Panel A: mock
transfection; panel B: transfection with T7EGFP; panel C: transfection with pcDNA3-NSP2; panel D: transfection with T7RFS8; panel E: transfection with
pT7V-NSP5; panel F: transfection with T7RFS11. Cell nuclei were stained with Hoechst 33342. Scale bars: 100 mm.
doi:10.1371/journal.pone.0074328.g009
Figure 10. Viroplasm-like structure (VLS) formation. MA104 cells were infected with FPV-T7 for one hour before co-transfection with pT7V-
NSP2 and pT7V-NSP5 plasmids using Lipofectamine 2000. Cells were fixed at 24 hours post transfection and stained for NSP2 and NSP5. Cell nuclei
were stained with Hoechst 33342. VLS and mock panels are merged images of UV and the other two composite excitations for NSP2 or NSP5. Images
were visualised by confocal microscopy. Arrows indicate VLS and location of enlarged inset images. Scale bars: 20 mm.
doi:10.1371/journal.pone.0074328.g010
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ssRNAs by Western blot for a variety of RV proteins. Media and
lysates were used to inoculate fresh MA104 monolayers and
incubated for 7 days in the presence of trypsin to activate potential
nascent RV. We concluded, based upon the cumulative data, that
the problem was most likely due to a block in protein translation
rather than to inadequate detection systems because after 7 days
even very low titers of nascent viruses would show RV viral protein
expression.
The paradox between successful expression of RV proteins in
RRL and undetectable expression in permissive cells from
transfected ssRNAs could be due to an increased concentration
of eIF-4E in RRL [71]. Over expression of eIF-4E has been shown
to increase synthesis of mRNAs with highly structured 59 ends
[72], it is therefore plausible that intact DLPs are able to recruit
this initiation cofactor whereas ssRNA alone cannot and only in
RRLs which possess increased eIF-4E concentrations can protein
expression be achieved to detectable levels. This would also
account for the observation that transfected DLPs are infectious
yet DLP-derived in vitro transcribed ssRNAs are not.
In order to test the potential of a RV helper-virus free system
based on cDNA transfection we used a FPV-T7 Pol recombinant
virus [57]. We hypothesized that a transfection system based on
cDNA, followed by intracellular transcription might facilitate
translation of RV proteins and rescue of infectious virus progeny.
The eGFP amplicon as a reporter linear cDNA molecule was
successfully transcribed and translated by this method, but again
we observed a lack of RV protein translation and virus recovery
when FPV-T7 recombinant-infected cells were transfected togeth-
er with 11 RV cDNAs. Even NSP2 and NSP5 provided in trans
(leading to the formation of VLS) [73] did not enable RV protein
expression or viral rescue. The delivery of nascent RV ssRNAs
into the cytoplasm from inside the cell was not sufficient to
enhance protein translation. Based on these data we concluded
that full length RV ssRNAs are non-infectious and incapable of
efficient translation in the cell lines investigated, whether derived
from cDNA- or ssRNA-based transfection.
The observation that both, DLP-derived ssRNAs and in vitro
transcribed ssRNAs from cDNAs, were not infectious when
transfected into susceptible cells was puzzling particularly since
DLPs transfected into cells can initiate protein expression and
infection [60]. Yet ssRNAs produced from these same particles
in vitro were not capable of acting as templates for translation when
transfected into permissive mammalian cells. Clearly there must be
something crucial and as yet unexplained about the cellular
location or the way in which the ssRNAs exit the DLPs in the
cytoplasm which permits viral protein synthesis and the subse-
quent steps of RV replication. Possibly ssRNAs exiting DLPs
interact immediately with ribosomes.
RV mRNAs are not polyadenylated. NSP3 binds the 39
consensus translation enhancer sequence, UGACC [41], but also
the carboxy terminal domain of eIF4GI, a functional homologue
of eIF4G, in the same region as PABP but with a higher affinity
[74,75]. Thus, NSP3 has been implicated in circularising RV
ssRNAs, facilitating greater expression of the proteins from non-
polyadenylated ssRNA [75]. Conversely, it has been suggested that
NSP3 is not required for protein expression [76,77,78]. NSP3 has
also been shown to shutdown host cell protein synthesis by
displacing PABP on cellular mRNAs [79]. It is known that host
cell protein synthesis is shut down almost completely during RV
infection through eIF2a phosphorylation [80]. Perhaps the key to
facilitating RV recovery from ssRNA lies in achieving a significant
shutdown of host cell protein synthesis by retention of polyade-
nylated cellular mRNA from the nucleus [38]. Our data show that
masking the RV ssRNAs by polyadenylating them so that they
appeared mRNA-like in structure did not lead to enhanced
translation or virus recovery; it is likely that the stability of these
polyadenylated ssRNAs would be equivalent to that of normal
mRNAs.
The sudden appearance of large amounts of highly structured
RV ssRNA molecules [32] in cells could trigger the innate immune
response, through the RIG-I and STAT pathways [81]. The
innate immune response can be blocked in cells which constitu-
tively express proteins inhibiting these pathways [81], and such cell
lines may be useful in future exploration of a RV RG system. The
continued pursuit of a ssRNA-based, helper virus-free system is
valid because of the report that polyadenylated reporter ssRNAs
are more efficient templates for translation when transfected
directly into the cytoplasm then when transcribed in the nucleus
from transfected cDNA [38].
The recent in vitro reconstitution of BTV using in vitro transla-
tion and ssRNA templates may be an approach worthy of
exploration to examine RV packaging signals and to construct
recombinant RV particles [82]. As the system does not depend on
viral particle formation in cells, cellular factors such as innate
immune responses are not a consideration. Obviating the need to
provide proteins in trans, this system may be useful for generating
RVs with mutations which are lethal or non-viable in cell-
dependent systems. As all the RV proteins can be translated from
ssRNAs in vitro, and based on the knowledge that VP2 and VP6
form DLP-like particles, this approach maybe a promising
direction for further research into RV RG systems.
Materials and Methods
Cells
The majority of experiments were performed with MA104 cells
(ATCC CRL-2378.1). Additional experiments were in COS-7
cells (ATCC CRL-1651), Vero cells (ATCC CRL-1586) and 293T
cells (ATCC CRL-11268). The cells were maintained in
Dulbecco’s Modified Eagle Medium (DMEM, PAA; Invitrogen)
which was supplemented with non-essential amino acids (0.1 mM),
penicillin (100 U/ml), streptomycin and (10 mg/ml) and 5% (for
Vero cells 10%) fetal calf serum (FCS). An MA104 cell line stably
expressing a C-terminal fusion of NSP5 to eGFP (termed NSP5-
eGFP) [46]; donation from Dr Oscar Burrone, Trieste) was
cultured as described above. All cells were cultured at 37uC in 5%
CO2/air atmosphere in a Sanyo incubator.
Viruses
The following RV strains were used: bovine RF (G6P6 [1]),
simian SA11 (G3P [2]), porcine OSU (G5P [7]) and human
bovine reassortants 125 and 128 containing gene rearrangements
in segments 8 and 11 (G6P [6]) [83]. Rotaviruses were propagated
and their infectivity (in TCID50/ml) titrated as described [84].
Virus Purification
Rotavirus stocks were grown and purified by concentration and
CsCl gradient equilibrium ultracentrifugation as described [85].
Preparations of triple-layered (TLP) and DLPs were obtained from
gradients and stored at 0 oC. Prior to use they were deionised
using a G25 Sephadex column as described [86].
Viral RNA Extraction
Viral dsRNA was extracted as described [84].The RNA
concentration was determined by absorbance at 260 nm using a
Nanodrop spectrophotometer (Nanodrop 1000, Thermo Scientif-
ic).
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Sequence Independent Amplification of Rotavirus RF
Strain Genomic Segments
cDNA copies of each genome segment were amplified from
viral dsRNA (extracted from purified DLPs) using the method of
full-length amplification of cDNAs (FLAC) [30] with the
modification of removing unincorporated anchor primer with a
Qiagen RNeasy Minelute column prior to reverse transcription.
The anchor primer and second primer [30] were supplied by
Eurogentec S.A. RNA-anchor primer ligation products were
purified by the RNeasy MinElute RNA purification column
(Qiagen). cDNA and dsDNA synthesis were achieved according to
[30]. Subsequently, RV ds-cDNA products were cloned into the
shuttle vector TOPO TA (Invitrogen), using the manufacturer’s
protocol. Clones were obtained from white colonies, amplified,
screened for inserts by PCR, restriction enzyme (RE) digestion and
their sequences were confirmed by Geneservice Cambridge or by
GATC Biotec Cambridge using the Sanger technique with M13F,
M13R and segment-specific sequencing primers. Terminal prim-
ers were designed to contain a truncated T7 Pol promoter at the
59end of each segment and appropriate restriction enzyme
recognition sites at the 39end [20]. Appropriate RV ds-cDNAs
were then subcloned into linearised plasmid pUC19. These
transcription constructs were again validated by sequencing. No
differences were found in comparison to the consensus sequences
except in segment 7 which encodes an additional 39 cytidine which
was retained as a genetic marker (unpublished data). The addition
of a single 39 cytidine is known not to affect VP1 recognition [87].
Lists of primers used to sequence RV cDNA clones and to
generate the appropriate amplicons are available upon request.
Large Scale Amplification of Plasmids
Large cultures (300 ml) in LB broth containing either ampicillin
(100 mg/ml) or kanamycin (50 m/ml) of plasmid containing
bacteria (E. coli DH5a) were prepared, and bacteria were
harvested by low speed centrifugation. Plasmids were purified
from the cell pellet using a Machery-Nagel maxi purification kit
according to the manufacturer’s protocols. Dried plasmid pellets
were resuspended in 100–500 ml sterile distilled water (SDW), and
the plasmid concentration was determined using a Nanodrop
spectrophotometer.
In vitro Transcription of viral Positive sense RNAs from
Digested pUC19T7 RV Templates
Firstly, plasmids were digested with either BsmBI, BsaI or BbsI
(Fermentas FastFigestH) according to the manufacturer’s instruc-
tions. To synthesise uncapped RV segmental mRNAs, 500 ng of
digested plasmids (to define the 39 end of the inserts) were used for
in vitro transcription by the MEGAscript T7 kit (Ambion)
according to the manufacturer’s protocol. For co-transcriptional
capping of ssRNAs, the Mmessage Mmachine T7 kit (Ambion)
was used with the following alterations: 1.5 ml of T7 RNA Pol
(Ambion; 20 u/ul) per reaction was added, and the amount of
linear template was increased to 1 mg for each reaction. Both un-
capped and co-capped reaction mixtures were incubated at 37uC
for 2.5 h. Transcripts were purified using the Qiagen Minelute
RNA purification kit and quantified by Nanodrop spectropho-
tometry. All ssRNAs were mixed in an equal volume of Fermentas
loading buffer and heated to 80uC for 10 min and cooled on ice
prior to loading on agarose gels.
Post-transciptional Cappping of ssRNAs
Purified uncapped ssRNAs synthesized in vitro (see above) were
post-transcriptionally capped using the ScriptCapTM m7G cap-
ping system (Cambio) according to the manufacturer’s protocol.
The post- transcriptionally capped ssRNAs were then purified as
described above. The quality of RNA transcripts was determined
by separation on 1.5% agarose gels using MOPS-EDTA
formaldehyde buffer or TBE in the presence of High Range
ssRNA RiboRulerTM markers (Fermentas). Purified ssRNA was
stored at 270uC.
Construction of eGFP Encoding cDNA and Reporter RNA
The eGFP ORF from plasmid pEGFP-N1 (donated by Dr Mike
Gill, University of Cambridge) was cloned into pUC19 under the
control of the T7 Pol promoter sequence. The eGFP PCR
amplicon corresponds to the transcription cassette in the original
plasmid. eGFP amplicons were synthesised using a PCR reaction
with KOD DNA polymerase (Novagen) and purified using a
Qiagen PCR cleaning up column (according to the manufacturer’s
instructions) prior to analysis by AGE. 5 mg of PCR amplicon was
digested with RE BsmBI (Fermentas FastDigestH) and then purified
as previously described. The digested amplicon was used for
ssRNA synthesis of uncapped and co-transcriptionally capped
RNAs. In addition, uncapped eGFP encoding RNA was post-
transcriptionally capped in vitro as described above.
Polyadenylation of ssRNAs
Both post- and co-transcriptionally capped RNAs were polyad-
enylated using an E. coli poly(A) polymerase in an Ambion
polyadenylation kit according to the manufacturer’s instructions.
Polyadenylated RNAs were purified and quantified as previously
described and successful polyadenylation was determined by
detecting a band shift using AGE.
In vitro Transcription from RV DLPs
DLPs were used as particles which are transcriptionally active
in vitro for the synthesis of ssRNAs from the encapsulated RV
genomes present in the protein shells as described [34,35,88]). In
brief, 0.5–1 ug of purified and deionised DLPs were incubated in a
transcription mixture of the following composition: Tris-HCl
buffer 100 mM pH 8, rNTPs 2 mM (rATP 4 mM), S-adenosyl
methionine chloride (Sigma) 500 mM, MgCl2 10 mM, MnCl2
100 uM, DTT 5mM, RNasin (Promega) 0.2 u/ml for 3 h at 42uC.
DLPs were removed by ultracentrifugation (60,000 g for 30 min),
and the ssRNAs precipitated by incubation at 4uC overnight in the
presence of 2M LiCl, followed by pelleting at 16,000 g for 10 min
at 4uC. The ssRNA pellets were extracted twice with phenol:-
chloroform to remove any residual protein from degraded DLPs,
precipitated and resuspended in nuclease-free water.
Transfection Experiments
Transfection experiments were performed with nearly confluent
MA104, COS-7, 293T, Vero cells in 24-, 12- or 6- well plates
using Opti-MEM I medium without serum and either Lipofecta-
mineTM 2000 (Invitrogen) or the TransITH-mRNA transfection kit
(Mirus) according to the relevant manufacturer’s instructions.
Some experiments were performed on coverslips for confocal
microscopy. DNA plasmids and cDNA amplicons were transfected
using Lipofectamine 2000, and ssRNAs were predominantly
transfected using the Mirus transfection reagent.
Attempt for Recovery of Infectious RV from Transfected
RNAs/cDNAs
Post transfection media and cell extracts were used to infect
confluent monolayers of MA104 cells, as previously described
[84], to check for the presence of infectious RV.
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Immunofluorescence Studies and Confocal Microscopy
Cells on coverslips were stained with specific antibodies (Table
S4) prior to visualisation by either epi-fluorescence (Nikon Eclipse
TE 300) or confocal microscopy (Leica TCS SP5 II).
Sodium Dodeccyl Sulfate Polyacrylamide Gel
Electrophoresis (SDS-PAGE)
SDS-PAGE was carried out as described [89].
Western Blotting
Protein samples run using SDS-PAGE were equilibrated in
transfer buffer (25 mM Tris-base, 0.2 M glycine, 20% ethanol,
pH 8.3) for 15 min prior to transfer onto HiBond-C membrane
(Amersham) with a Trans-Blot 3D Semi-Dry transfer cell (BioRad)
at 45 mA for 45 min. Membranes were cut into appropriate
horizontal strips and were blocked in 5% Milk/PBS/0.05%
Tween (Sigma) overnight at 4uC. Membranes were then washed
with PBS/0.05% Tween three times prior to incubation for 2
hours with appropriately diluted primary antibodies (Table S5),
washed and incubated with anti-species specific secondary
antibodies conjugated to horseradish peroxidase (HRP) (Table
S5), for 1 hour in 1% milk/PBS. Membranes were washed prior to
developing with ECL Western blotting substrate (Pierce) and
exposed to X-ray film.
In vitro Translation of RV Proteins from RV RNA
Transcribed in vitro from cDNA Clones or Purified DLPs
Purified ssRNAs were used as templates for protein synthesis in
a RRL expression system (Ambion) incorporating radiolabelled L-
[35S]- methionine (Perkin Elmer; specific activity 1000 Ci/mM). A
range of 100 ng –1 mg of ssRNA was incubated with the cell lysate
according to the manufacturer’s instructions. Aminoacyl tRNAs
(and template ssRNAs) were removed by digestion with 2.5 ml
RNase One ribonuclease (Promega, 10 U/ml) at 30uC for 15 min.
Reaction mixtures were separated by SDS-PAGE as described
above. After electrophoresis proteins were fixed in [45% methanol:
10% acetic acid: SDW] for 15 min and incubated with the
fluorographic reagent Amplify (Amersham) for 15 min, prior to
drying for 60 min at 80uC. Dried gels were exposed to X-ray film
at 4uC (Konica) for varying lengths of time. Films were developed
using a Konica Minolta SRX-101A X-ray film processor.
Intracellular Transcription of RV RNAs and eGFP Reporter
RNAs
FPV recombinant expressing T7 Pol (FPV-T7) [57] was a gift
from Drs Ian Goodfellow and Michael Skinner (Imperial College
London). FPV-T7 was used to drive intracellular transcription in
MA104, COS-7 or Caco-2 cells from cDNA amplicons encoding
RV genomic segments or eGFP. Cells were infected with FPV-T7
for one hour and then transfected with the cDNAs, digested to
define the 39 end of transcription products, using Lipofectamine-
2000 as previously described. Infected and transfected cells were
stained with RV-specific antibodies (Table S4) to detect protein
expression and visualised using either epi-fluorescence or confocal
microscopy, as described above.
Production of VLS from cDNA Clones using a FPV-T7
Recombinant
VLS [73] were created by transfecting plasmids encoding NSP2
or NSP5 into FPV-T7 infected cells. This was achieved by co-
expression of NSP2 and NSP5 from pcDNA3-NSP2 or pcDNA3-
NSP5 (both were gifts from Oscar Burrone, Triest, Italy). Plasmid
transfection was achieved using Lipofectamine as previously
described.
DNA and Protein Sequence Analysis
The methods ClustalX2 [90] and Blast [91] were used to align
cloned RV cDNA sequences and compare with other sequences,
respectively. Protein sequences were analysed with Jalview [92].
Supporting Information
Figure S1 RV cDNA synthesis using the FLAC proce-
dure. Using the FLAC procedure, RV cDNA was synthesised for
all 11 RV segments in a single reaction. Purified dsRNA-anchor
primer hybrids were used in a self-priming RT reaction prior to
amplification by PCR and a primer, 5-15-1, complementary to a
region of the anchor primer sequence. Lane 1:110 ng dsRNA,
Lanes 2–4:1:3, 1:10 and 1:30 dilutions of a RV cDNA, lane M:
HyperLadderTM I DNA markers (in bp). Samples were analysed
using a 20 mM MOPS Tris pH 7.7 AGE for 65 min at 60 V. It
should be noted that segments 10 and 11 apparently comigrate in
lanes 2–4; this is possibly due to migration differences of segment-
anchor primer complexes. Segment 10 and 11 cDNAs were both
successfully cloned from this experiment.
(TIF)
Figure S2 T7 cassettes amplicons for each RV segment.
A clone for each RV segment was selected as the target to generate
amplicons containing the T7 Pol promoter cassette amplicons.
Primers were designed to specifically bind to the 59 and 39 termini
of the particular segment of choice. Amplicons were either
digested with the RE to define the 39 end and transfected into cells
as intracellular transcription templates by T7 Pol or digested with
REs to facilitate cloning into pUC19. Each lane represents 5% of a
PCR reaction which generated an amplicon of a RV segment. M:
HyperLadderTM I DNA markers (in bp), panel A : segments 1–6;
panel B: segments 7–11, respectively.
(TIF)
Figure S3 Comparison between the RNA structures of
the 59 and 39 termini using RNAfold. Comparison of
minimum free energy structures of RV RF strain ssRNAs using
sequences obtained from GenBank and the consensus sequences
derived from the FLAC cloned cDNAs. The consensus sequences
were derived from the sequencing data of cDNAs introduced into
the TOPO vector. The location of each 59 and 39 terminus is
indicated, and black arrowheads indicate the location of
sequencing alterations, specific details of which are found in
Table S3. The colour of each base indicates the base-pairing
probability as indicated by the colour scale. RNA structures were
determined using RNAfold [93]. Segments 1, 6 and 9 did not
encode mutations and have therefore been excluded.
(TIF)
Figure S4 In vitro transcription and translation of
segment 3 from the RV SA11 strain. Panel A, in vitro
transcription products from RV RF and SA11 strains using 1 mg of
segment 3 cDNA BsmBI digested templates. RNAs were synthe-
sised in the presence of a cap analogue. 600 ng of ssRNA was
loaded onto the gel; 1.5% TBE AGE 80 V for 45 min. Lane R:
RiboRulerTM High Range; lanes 1 & 2: positive sense capped
ssRNA of RV RF and SA11 strains, respectively. Panel B, in vitro
translation of RV segment 3 ssRNAs of RF and SA11,
respectively. 500 ng of co-capped ssRNA was incubated in a
RRL as described, electrophoresed alongside PageRulerTM
protein markers (in kDa) using 15% SDS-PAGE and exposed to
X-ray film for 3 days. Lane 1: no ssRNA (negative control); lanes 2
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& 3: segment 3 co-capped ssRNA of RV RF or SA11 strains,
respectively. 4: XEF ssRNA (positive control).
(TIF)
Figure S5 Polyadenylation of RV positive sense ssRNA.
Purified in vitro synthesised RV ssRNA was polyadenlyated in the
same manner as eGFP mRNA for 1 hour at 37uC. 2% TBE AGE,
75 V for 90 min. Lane R: RiboRulerTM High Range; lanes (L) 1–
8:500 ng of ssRNAs of: L1: segment 8; L2: segment 8
polyadenylated; L3: segment 1; L4: segment 1 polyadenylated;
L5: segment 9; L6: segment 9 polyadenylated; L7: segment 11; L8:
segment 11 polyadenylated.
(TIF)
Figure S6 COS-7 and MA104 cells transfection with
polyadenylated RV RNAs.MA104 (Panels A & B) and COS-7
cells (panels C & D) were fixed and stained to detect RV proteins,
NSP2, NSP5 or VP1. Transfection experiments (panels A and C)
were stained for NSP2, NSP5, VP1 and both NSP2 & NSP5,
respectively. Panels A and C were controlled by transfection of
500 ng of eGFP mRNA yielding autofluorescence prior to staining
(unpublished data). Panels B and D were infected with RV RF
strain and were used a positive control. Panel B was stained for
NSP2 and NSP5. Panel D was stained for VP1. Cell nuclei were
stained with Hoechst 33342. Scale bars: 20 mm.
(TIF)
Figure S7 Absence of VP2 and VP6 protein expression
determined by immunofluorescence from transfected
ssRNAs encoding either VP2 or VP6. Panel A COS-7 and
panel B MA104 cells at 80% confluence were transfected with
ssRNAs encoding RV proteins using Mirus transfection reagent.
Cells were fixed at 24 hours post transfection and stained with VP2
and VP6-specific antibodies (Table S4). Images were analysed by
confocal microscopy. Cells were transfected with 1 mg of in vitro
transcribed post-capped ssRNAs of S2, S6 or eGFP control
(autofluorescencet transfection control). Immunofluorescence of
COS-7 and MA104 cells infected with RF RV were stained for
VP2 and VP6 (viral protein control), respectively. Cell nuclei were
stained with Hoechst 33342 in all panels. Scale bars: 20 mm.
(TIF)
Figure S8 Confirmation by Western blotting of ineffi-
cient VP2 and VP6 protein expression from transfected
ssRNA. Cells, either COS-7 (panels A and B) or MA104 (panels
C and D) were transfected with 1 mg of RV ssRNA using the
Mirus TransITTM mRNA transfection reagent. Expression of RV
proteins from cell lysates was sought by Western blot after
separation using SDS-PAGE. The membranes, panels A and C
were split into three sections to ascertain the presence of VP2,
170–70 kDa or loading control a tubulin, 70 - 40 kDa or VP6,
40–15 kDa respectively. Panels B and D, were split in two to
detect a tubulin (protein loading control), 70 - 40 kDa and eGFP
(transfection control) 40–15 kDa. Each membrane section was
incubated with the respective primary and secondary horseradish
peroxidase (HRP) conjugated antibody (Table S5). Proteins were
visualised using the ECL Western blot detection reagents, light
sensitive film was exposed to membranes for varying lengths of
time depending on band intensity. Lane 1: mock; lanes (L) 2 - 6,
in vitro transcribed ssRNAs or infected cell lysates. Lane 2: S2,
L3:VP2, L4: S6, L5: VP6, L6: eGFP.
(TIF)
Table S1 GenBank accession numbers for RV RF strain
shotgun cloned cDNA sequences.
(DOC)
Table S2 GenBank accession numbers for in vitro
transcription template consensus sequences.
(DOC)
Table S3 Formation of consensus sequences for each
RV genomic segment.
(DOC)
Table S4 Primary and secondary antibodies used for
confocal microscopy.
(DOC)
Table S5 Primary and secondary antibodies used for
Western blotting.
(DOC)
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